Rani Therapeutics Holdings, Inc. Class A Common Stock

RANINASDAQ • USD
0.56 USD
↘ 0.02 (4.06%)🟢LIVE (AS OF 11:47 AM EST)
🟢Market: OPEN

Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) trades at $0.56 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, RANI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 19, 2026.

Open?$0.58
High?$0.59
Low?$0.54
Prev. Close?$0.58
Volume?146.2K
Avg. Volume?559.2K
VWAP?$0.57
Rel. Volume?0.26x
Bid / Ask
Bid?$0.48 × 100
Ask?$0.65 × 100
Spread?$0.16
Midpoint?$0.57
Valuation & Ratios
Market Cap?67.0M
Shares Out?115.5M
Float?78.2M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?1.97
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Employees
69
Market Cap
67.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-30
Address
47709 FREMONT BLVD
FREMONT, CA 94538
Phone: (408) 457-3700
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.70Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.51%High
Short Interest?8.2M
Days to Cover?17.2
Free Float78.2M
Avg Daily Volume477.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.26Strong
Quick Ratio?5.26Strong
Cash Ratio?0.39Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
75
1.97CHEAP▾
P/S?
Peers
100
S&P
8
10.17HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.9CHEAP▾
EV/Sales?
Peers
100
S&P
12
9.62HIGH▾
Returns & Efficiency
ROE?
S&P
3
-95.5%WEAK▾
ROA?
S&P
3
-61.8%WEAK▾
Cash Flow & Enterprise
FCF?$-23220000
Enterprise Value?$63.4M
Fundamentals ratios updated end of day